PA Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $746K | Buy |
7,658
+2,322
| +44% | +$226K | 0.52% | 66 |
|
|
2020
Q2 | $833K | Sell |
5,336
-202
| -4% | -$31.5K | 0.6% | 60 |
|
|
2020
Q1 | $799K | Buy |
5,538
+1,654
| +43% | +$239K | 0.71% | 59 |
|
|
2019
Q4 | $794K | Buy |
3,884
+42
| +1% | +$8.59K | 0.7% | 53 |
|
|
2019
Q3 | $308K | Sell |
3,842
-3,354
| -47% | -$269K | 0.3% | 96 |
|
|
2019
Q2 | $679K | Sell |
7,196
-2,675
| -27% | -$252K | 0.62% | 59 |
|
|
2019
Q1 | $844K | Sell |
9,871
-3,915
| -28% | -$335K | 0.75% | 44 |
|
|
2018
Q4 | $773K | Buy |
+13,786
| New | +$773K | 0.82% | 42 |
|